SMS Pharmaceuticals Limited — Others, 09-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

SMS Pharmaceuticals has announced a board meeting regarding compliance with SEBI guidelines, specifically under Regulation 74(5) for the quarter ended 31st March 2025. A certificate from Aarthi Consultants confirms that the necessary dematerialization actions have been completed, ensuring all securities are properly registered and listed.

This update reinforces the company's commitment to governance standards and operational efficiency. Investors might view this as a positive outlook, reflecting the company's adherence to compliance and management practices, potentially enhancing trust in its governance framework.